CHICAGO, Sept. 06, 2017 -- Typenex Medical, an industry leader in medical devices and supplies, announced today it is bringing Rad-Control, a new irradiation indicator tag technology, to blood banks and blood centers in the United States and Canada. Typenex Medical has exclusively partnered with a European market leader, On Point Indicators GmbH, to offer the product to its customers. The product technology confirms blood irradiation by visual verification, minimizes current documentation practices and increases efficiency for healthcare staff.
“The irradiation indicator tag market has not seen innovation within the last decade. We are excited to launch Rad-Control, and breathe some life into this market,” said John Fife, owner, and chief executive officer (CEO), Typenex Medical. “With increasing pressures on healthcare facilities to do more with less, we are positioned to help improve workflows while providing compelling value.”
Rad-Control is used in hospitals and blood centers to ensure the blood component has been exposed to irradiation. The specially-formulated indicator technology in the tag changes color after exposure, acting as a visual verification. This practice has been common in ensuring blood components are irradiated, confirming that components have received irradiation, and helping to prevent multiple irradiation cycles. Properly irradiating blood helps to prevent life threatening Transfusion-Associated Graft-vs.-Host Disease (TA-GvHD).
Current practices are built around irradiation tags that must be stored in a refrigerated environment. Rad-Control can be stored at room temperature, eliminating repetitive trips from the irradiator to the refrigerated storage location. Additionally, many facilities document the irradiation tag-lot number and expiration information by hand in their logbook. The Rad-Control irradiation indicator tag features an easy peel off label that, instead, can be placed directly into the logbook – saving time and ensuring accuracy.
“On one hand, it is easier to store the tags near the machine, and on the other, it is easier to accurately document the use of the product,” said Brad Palmer, Director of New Product Development, Typenex Medical. “The biggest feedback we hear from our customers is that our irradiation indicator tag allows for better workflows. With our strong reputation in blood banks around the country, we are excited to bring superior solutions to the market that can help meet customer needs.”
Typenex Medical has been a leading blood bank and laboratory supplier for more than 10 years. The company maintains a considerable market share in the medical device and supply industry, and is continuing to expand to other areas of the hospital – including the operating room.
About Typenex Medical, LLC
Typenex® Medical is a medical device and supply company founded by entrepreneur and investor, John Fife. The Typenex Medical advantage is connecting with customers to understand their process needs, then delivering simple, high-quality products that streamline workflows. Thinking about patient safety and comfort is a strength, along with efficiency and cost-effectiveness – all while providing a quality product. For more information please visit www.typenexmedical.com.
Contact: Amanda Jaron Product Manager – Blood Bank and Lab 312-888-4097 [email protected]


Italy Fines Apple €98.6 Million Over App Store Dominance
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 



